Literature DB >> 7181829

The inability of isoproterenol or propranolol to alter the lateral dimensions of experimentally induced myocardial infarcts.

J M Downey, D Chambers, R D Wilkerson.   

Abstract

The relationship between the blood flow pattern immediately following coronary artery occlusion and the resulting infarct 24 hours later was studied in dogs treated with isoproterenol (0.5 micrograms/kg/min for 2 hours) or with propranolol (2 mg/kg every 6 hours). The coronary artery of a closed chest dog was perfused via a special cannula with arterial blood. A 2-mm diameter plastic bead was introduced into the perfusate to embolize a coronary branch. One minute after occlusion, radiolabelled microspheres were injected into the perfusate. The dogs were then allowed to recover. 24 hours later the dogs were reanesthetized and their hearts removed. The hearts were sliced into 4 mm thick sections and the microsphere distribution was visualized by autoradiography of the tissue. Superimposition of developed autoradiographs and tracings of the infarct pattern of stained sections allowed direct comparison of the blood flow pattern immediately after occlusion to the eventual pattern of infarction. In all 8 control dogs, all 6 isoproterenol dogs and all 12 propranolol dogs the lateral borders of blood flow and infarction were superimposable indicating no lateral change in infarct size resulting from treatment. In the control group there was a subepicardial region of the ischemic zone which did not infarct (15.2 +/- 2.3% of the ischemic zone). Though isoproterenol did not significantly change the size of this zone, propranolol increased it to 35.9 +/- 6,5% (p less than 0.005) indicating vertical but not lateral salvage.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7181829     DOI: 10.1007/bf01907941

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  32 in total

1.  Factors influencing infarct size following experimental coronary artery occlusions.

Authors:  P R Maroko; J K Kjekshus; B E Sobel; T Watanabe; J W Covell; J Ross; E Braunwald
Journal:  Circulation       Date:  1971-01       Impact factor: 29.690

2.  Effect of indomethacin on collateral blood flow and infarct size in the conscious dog.

Authors:  B I Jugdutt; G M Hutchins; B H Bulkley; B Pitt; L C Becker
Journal:  Circulation       Date:  1979-04       Impact factor: 29.690

3.  Myocardial infarction in the conscious dog: three-dimensional mapping of infarct, collateral flow and region at risk.

Authors:  B I Jugdutt; G M Hutchins; B H Bulkley; L C Becker
Journal:  Circulation       Date:  1979-11       Impact factor: 29.690

4.  On the nature of protection by propranolol against myocardial necrosis after temporary coronary occlusion in dogs.

Authors:  K A Reimer; M M Rasmussen; R B Jennings
Journal:  Am J Cardiol       Date:  1976-03-31       Impact factor: 2.778

5.  Effects of time on volume and distribution of coronary collateral flow.

Authors:  M L Marcus; R E Kerber; J Ehrhardt; F M Abboud
Journal:  Am J Physiol       Date:  1976-02

6.  Failure of high doses of propranolol to reduce experimental myocardial ischemic damage.

Authors:  T Peter; M K Heng; B N Singh; P Ambler; H Nisbet; R Elliot; R M Norris
Journal:  Circulation       Date:  1978-03       Impact factor: 29.690

7.  Demonstration of lateral and epicardial border zone salvage by flurbiprofen using an in vivo method for assessing myocardium at risk.

Authors:  J R Darsee; R A Kloner; E Braunwald
Journal:  Circulation       Date:  1981-01       Impact factor: 29.690

8.  Linear relationship between perfusion area and infarct size.

Authors:  M Nakamura; H Tomoike; K Sakai; H Ootsubo; Y Kikuchi
Journal:  Basic Res Cardiol       Date:  1981 Jul-Aug       Impact factor: 17.165

9.  Direct metabolic effects of isoproterenol and propranolol in ischemic myocardium of the dog.

Authors:  M Goodlett; K Dowling; L J Eddy; J M Downey
Journal:  Am J Physiol       Date:  1980-10

10.  The "no-reflow" phenomenon after temporary coronary occlusion in the dog.

Authors:  R A Kloner; C E Ganote; R B Jennings
Journal:  J Clin Invest       Date:  1974-12       Impact factor: 14.808

View more
  2 in total

1.  Reduction of regional contractile function by preconditioning ischemia does not play a permissive role in the infarct size-limitation by the preconditioning.

Authors:  M Goto; T Miura; M Itoya; J Sakamoto; O Iimura
Journal:  Basic Res Cardiol       Date:  1993 Nov-Dec       Impact factor: 17.165

2.  Limitation of myocardial necrosis with verapamil during sustained coronary occlusion in the closed-chest dog.

Authors:  J G Kingma; D M Yellon
Journal:  Cardiovasc Drugs Ther       Date:  1988-09       Impact factor: 3.727

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.